SRC
CVS icon

Shufro Rose & Co’s CVS Health CVS Stock Holding History

Shufro Rose & Co’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$202K Buy
+1,950
New +$174K 0.01% 292
2025
Q4 		– Sell
-4,450
Closed -$301K – 313
2025
Q3 		$301K Sell
4,450
-500
-10% -$34.3K 0.02% 239
2025
Q2 		$335K Hold
4,950
– – 0.03% 222
2025
Q1 		$335K Sell
4,950
-3,279
-40% -$196K 0.03% 226
2024
Q4 		$369K Sell
8,229
-182
-2% -$10.2K 0.03% 205
2024
Q3 		$497K Hold
8,411
– – 0.04% 172
2024
Q2 		$497K Hold
8,411
– – 0.04% 172
2024
Q1 		$671K Buy
8,411
+250
+3% +$19.1K 0.06% 136
2023
Q4 		$570K Hold
8,161
– – 0.05% 147
2023
Q3 		$570K Hold
8,161
– – 0.05% 146
2023
Q2 		$564K Sell
8,161
-450
-5% -$32K 0.05% 153
2023
Q1 		$640K Sell
8,611
-4,220
-33% -$354K 0.06% 147
2022
Q4 		$1.2M Sell
12,831
-800
-6% -$77.2K 0.1% 104
2022
Q3 		$1.3M Sell
13,631
-522
-4% -$51.7K 0.13% 91
2022
Q2 		$1.31M Hold
14,153
– – 0.11% 93
2022
Q1 		$1.43M Sell
14,153
-1,209
-8% -$127K 0.11% 100
2021
Q4 		$1.58M Sell
15,362
-150
-1% -$13.9K 0.11% 99
2021
Q3 		$1.32M Buy
15,512
+1,806
+13% +$151K 0.1% 100
2021
Q2 		$1.14M Sell
13,706
-1,015
-7% -$83.1K 0.09% 106
2021
Q1 		$1.11M Buy
14,721
+175
+1% +$12.7K 0.09% 104
2020
Q4 		$993K Buy
14,546
+256
+2% +$16.7K 0.08% 113
2020
Q3 		$835K Buy
14,290
+2,200
+18% +$137K 0.08% 113
2020
Q2 		$785K Buy
12,090
+500
+4% +$31.5K 0.08% 116
2020
Q1 		$688K Sell
11,590
-535
-4% -$35.7K 0.08% 117
2019
Q4 		$901K Sell
12,125
-914
-7% -$64.2K 0.08% 119
2019
Q3 		$822K Sell
13,039
-64
-0.5% -$3.79K 0.08% 122
2019
Q2 		$714K Buy
13,103
+439
+3% +$23.6K 0.07% 134
2019
Q1 		$683K Sell
12,664
-360
-3% -$22.2K 0.07% 140
2018
Q4 		$853K Sell
13,024
-800
-6% -$59.7K 0.09% 117
2018
Q3 		$1.09M Sell
13,824
-100
-0.7% -$7.15K 0.1% 117
2018
Q2 		$896K Sell
13,924
-390
-3% -$25.7K 0.09% 128
2018
Q1 		$890K Hold
14,314
– – 0.09% 127
2017
Q4 		$1.04M Sell
14,314
-242
-2% -$17.6K 0.1% 116
2017
Q3 		$1.18M Sell
14,556
-250
-2% -$19.8K 0.12% 112
2017
Q2 		$1.19M Buy
14,806
+389
+3% +$30.7K 0.13% 106
2017
Q1 		$1.13M Sell
14,417
-390
-3% -$31.1K 0.12% 113
2016
Q4 		$1.17M Buy
14,807
+332
+2% +$26.9K 0.13% 101
2016
Q3 		$1.29M Sell
14,475
-650
-4% -$61.4K 0.14% 94
2016
Q2 		$1.45M Sell
15,125
-25
-0.2% -$2.49K 0.16% 94
2016
Q1 		$1.57M Buy
15,150
+1,000
+7% +$97.2K 0.18% 90
2015
Q4 		$1.38M Sell
14,150
-80
-0.6% -$7.83K 0.16% 97
2015
Q3 		$1.37M Sell
14,230
-70
-0.5% -$7.36K 0.16% 97
2015
Q2 		$1.5M Sell
14,300
-50
-0.3% -$5.11K 0.16% 93
2015
Q1 		$1.48M Sell
14,350
-300
-2% -$30.4K 0.15% 94
2014
Q4 		$1.41M Sell
14,650
-250
-2% -$22K 0.14% 102
2014
Q3 		$1.19M Sell
14,900
-600
-4% -$47.3K 0.12% 111
2014
Q2 		$1.17M Sell
15,500
-800
-5% -$60.5K 0.12% 109
2014
Q1 		$1.22M Hold
16,300
– – 0.13% 99
2013
Q4 		$1.17M Sell
16,300
-250
-2% -$16.1K 0.12% 99
2013
Q3 		$939K Hold
16,550
– – 0.11% 112
2013
Q2 		$946K Buy
+16,550
New +$959K 0.11% 107

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Shufro Rose & Co's CVS Position: Q2 2026 in Review

Shufro Rose & Co opened a new position in CVS Health (CVS) in Q2 2026: 1,950 shares worth $202K. The stake represents 0.01% of the portfolio and ranks #292 among its holdings. This is a return to the name: Shufro Rose & Co previously reported a position in CVS as recently as Q3 2025.

Shufro Rose & Co first reported a position in CVS in Q2 2013 and has held it in 51 quarters since. The position peaked at $1.58M in Q4 2021. 2,062 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Shufro Rose & Co held 1,950 shares of CVS Health worth $202K as of Q2 2026.
  • CVS Health was a new Shufro Rose & Co position in Q2 2026.
  • CVS Health made up 0.01% of Shufro Rose & Co's portfolio in Q2 2026, its #292 holding.
  • Shufro Rose & Co first reported a position in CVS Health in Q2 2013 and has held it in 51 quarters since.
  • Shufro Rose & Co's CVS Health position peaked at $1.58M in Q4 2021.
  • 2,062 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Shufro Rose & Co's 13F filing for Q2 2026, filed 12 Aug 2026.